Prevention of Cutaneous Larva Migrans in Dogs and Cats: Specific Deworming Protocols
To prevent cutaneous larva migrans transmission from dogs and cats, deworm pets with ivermectin 200 μg/kg as a single oral dose monthly, or albendazole 400 mg orally once daily for 3 days, targeting the causative hookworms Ancylostoma braziliense and A. caninum. 1
Understanding the Prevention Strategy
Cutaneous larva migrans in humans results from skin penetration by dog and cat hookworm larvae (Ancylostoma braziliense and A. caninum) present in soil contaminated by animal feces 1. Prevention focuses on eliminating these parasites from companion animals before they can contaminate the environment.
Specific Anthelmintic Regimens for Dogs and Cats
Primary Prevention Options:
Option 1: Ivermectin (Preferred for Monthly Prevention)
- Dose: 200 μg/kg (0.2 mg/kg) body weight
- Route: Oral (PO)
- Frequency: Single dose monthly for ongoing prevention 2
- Quantity to dispense: Calculate based on pet's weight; for a 10 kg dog = 2 mg per dose, dispense 6 doses for 6-month supply
- Sig: Give one dose by mouth monthly on the same date each month
Option 2: Albendazole (For Treatment Cycles)
- Dose: 400 mg for adult dogs/cats (or 15 mg/kg for smaller animals)
- Route: Oral (PO)
- Frequency: Once daily for 3 consecutive days 1
- Quantity to dispense: 3 tablets per treatment cycle
- Sig: Give one 400 mg tablet by mouth once daily for 3 days; repeat every 3-6 months
Alternative Regimens:
Mebendazole:
- Dose: 22 mg/kg body weight
- Route: Oral powder
- Frequency: Once daily for 3-5 days 3
- Efficacy: 99.4-100% against Ancylostoma caninum 3
Oxibendazole:
- Dose: 15 mg/kg body weight
- Route: Oral paste
- Frequency: Single dose, repeat at 2,4, and 6 weeks for puppies 4
- Efficacy: 94.6% against A. caninum 4
Critical Implementation Details
For Puppies and Kittens:
Start deworming at 2 weeks of age, then repeat at 4 and 6 weeks using oxibendazole 15 mg/kg or mebendazole 22 mg/kg 4. This targets the prepatent period before larvae are shed into the environment.
For Adult Animals:
Maintain monthly ivermectin prophylaxis year-round in endemic areas (tropical and subtropical regions) 1, 5. In temperate climates, consider seasonal prophylaxis during warmer months when larvae survive in soil.
Combination Therapy Consideration:
Emerging resistance to single-agent therapy has been documented 6. For animals in high-risk environments or with treatment failures, consider:
- Ivermectin 200 μg/kg PLUS Albendazole 400 mg given concurrently
- This combination addresses potential multidrug-resistant hookworm strains 6, 7
Important Caveats and Pitfalls
Breed-Specific Contraindications: Ivermectin is contraindicated in Collies, Shelties, Australian Shepherds, and other herding breeds with MDR1 gene mutations. Use albendazole or mebendazole alternatives in these breeds.
Pregnancy and Lactation: Ivermectin and albendazole have limited safety data in pregnant/lactating animals. Consult veterinary guidance, though ivermectin is generally considered compatible with lactation at preventive doses 1.
Environmental Management: Medication alone is insufficient. Implement concurrent measures:
- Remove feces from yards daily before larvae develop (requires 5-10 days)
- Restrict pet access to children's sandboxes and play areas
- Cover sandboxes when not in use
- Treat all household pets simultaneously
Monitoring for Resistance: If fecal egg counts remain elevated after treatment, or if human cases occur despite pet prophylaxis, suspect anthelmintic resistance 6. Switch to combination therapy (ivermectin + albendazole) rather than increasing single-agent doses.
Practical Prescribing Example
For a 20 kg dog in an endemic area:
- Rx: Ivermectin 0.2 mg/kg oral solution
- Dose: 4 mg (20 kg × 0.2 mg/kg) = 0.4 mL of 1% solution
- Sig: Give 0.4 mL by mouth once monthly
- Quantity: 12 mL (for 12-month supply)
- Refills: 0 (reassess annually)
The evidence strongly supports ivermectin as first-line prevention due to its monthly dosing convenience and broad-spectrum efficacy against multiple parasites 2. Albendazole serves as an effective alternative for ivermectin-intolerant animals or for quarterly treatment cycles 1.